Research

Independent fundamental research across global equities, commodities, and actionable investment themes.

Please note

This page presents a preview of our institutional coverage. Individual investors are best served through our subscription-based platform and live model portfolio below.

Our research platform covers the companies, stocks, and themes shaping global markets. It is trusted by over 4,000 investors, business owners, executives, and researchers who want in-depth, independent analysis free from Wall Street bias.

Research Breadth

Aurelion Research provides institutions with differentiated coverage across global equities, investment themes, and commodities. Our output is highly selective, focusing on high-conviction ideas and material updates.

Global Equities

Small & Mid-Caps

We target under-researched equities where price diverges from fundamentals. Our process relies on primary research, including management contact, on-site diligence, and financial modeling.

Coverage is independent and driven by conviction, not by conflicts of interest. We initiate only where we see an opportunity, maintaining a selective and high-conviction universe.

Actionable Thematics

Thematic Equity

We analyze major global market trends through a top-down lens, with a focus on mispriced or underfollowed themes before they reach consensus.

Our thematic research translates these dynamics into actionable investment frameworks and equity opportunities for portfolio construction.

Commodity Markets

Cyclical Inflection Points

We focus on commodity sectors where the market misreads supply and demand, identifying inflection points before they are priced in. Coverage spans energy, shipping, chemicals, and precious metals.

Our historical calls include the 2025 chemical rebound, the shipping rate recovery, and the precious metals bull market.

Preview of Our Research

CompanyTickerReport TypeAnalyst CoverageLink
Bruker CorporationNASDAQ: BRKRChange of RatingLéo-Pierre TrudelDownload PDF
Calian Group Ltd. TSE: CGYInitiating CoverageLéo-Pierre TrudelDownload PDF
Cellebrite DI Ltd.NASDAQ: CLBTInitiating CoverageJérémie Boyer, Léo-Pierre TrudelDownload PDF